Autologous Cell Suspension Grafting Using ReCell in Vitiligo and Piebaldism Patients
Clinical trial NCT02458417 · COMPLETED
Trial details
- NCT number
- NCT02458417
- Sponsor
- Netherlands Institute for Pigment Disorders
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2016-01-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.